U.S. Gas Utilities Stock News

NasdaqGS:VIOT
NasdaqGS:VIOTConsumer Durables

3 Promising Penny Stocks Under $200M Market Cap

The market remained flat over the last week, but over the past 12 months, it has risen by 17%, with earnings forecast to grow by a similar margin annually. For investors looking beyond well-known names, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities. While the term 'penny stocks' might seem outdated, these investments still hold potential for growth when backed by strong financials; here we explore three such stocks that stand out for their...
NasdaqCM:ESEA
NasdaqCM:ESEAShipping

3 Dividend Stocks To Consider For Your Portfolio

The United States market remained flat over the last week but has seen a 17% increase over the past year, with earnings expected to grow by 17% annually in the coming years. In such an environment, dividend stocks can offer investors a reliable income stream and potential for capital appreciation, making them an appealing option for those looking to enhance their portfolios.
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

DexCom (DXCM) Stock Still Looks Undervalued Against Fair Value

DexCom stock has delivered a decline of about 35% over the past 5 years, yet a Discounted Cash Flow (DCF) intrinsic value estimate currently points to meaningful upside compared with the recent US$88.96 share price. At the same time, the broader valuation checks lean expensive overall, which leaves investors weighing a discounted intrinsic estimate against a weaker score on other metrics. Over the past 5 years, DexCom shares are down roughly 35%, which means long term holders have so far not...
NasdaqGS:CWST
NasdaqGS:CWSTCommercial Services

Casella Waste Systems (CWST) Could Be 16% Undervalued Following Its Recent Rebound

Casella Waste Systems (CWST) is back on investor radars after recent share price moves, with the stock closing at $93.74. That is putting fresh attention on how its fundamentals line up today. Recent moves in Casella Waste Systems reflect a stock that has picked up some short term momentum, with a 30 day share price return of 4.97% and a 90 day share price return of 11.30%. However, total shareholder return over the past year is still down 6.41%, while the 5 year total shareholder return of...
NYSE:CCI
NYSE:CCISpecialized REITs

Crown Castle (CCI) Stock May Be 33% Undervalued Despite Debt Cut Uncertainty

Crown Castle stock has fallen sharply over the past few years, yet current valuation checks suggest the market price may sit below a reasonable intrinsic value estimate based on its cash flow outlook. With both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples pointing to undervaluation, investors are weighing whether the recent share price weakness has already more than accounted for the key risks. Crown Castle shares are down about 51.5% over 5 years, which...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson & Johnson (JNJ) Has Investors Asking Questions Today

Johnson & Johnson (JNJ) shares are trading against the backdrop of a fresh U.S. Food and Drug Administration approval for Imaavy, the first and only treatment specifically cleared for warm autoimmune hemolytic anemia. Despite the short term share price pullback of around 1% on the day of the Imaavy announcement, Johnson & Johnson’s recent approvals in wAIHA and atrial fibrillation come against a stronger backdrop. The 90 day share price return of 16.98% and the 1 year total shareholder return...
NYSE:HD
NYSE:HDSpecialty Retail

Home Depot (HD) Stock Looks Overvalued Following Its 17% Five Year Gain

Home Depot stock is caught between two very different valuation reads right now, with a Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares trade at a premium, while market based multiples still point to a discount relative to fundamentals. That split comes after a 5 year return that is positive but not extreme, which leaves investors weighing how much optimism is already reflected in the current price. Home Depot has returned about 16.6% over the past 5 years, which...
NYSE:PBI
NYSE:PBICommercial Services

Is Pitney Bowes (PBI) Using Cash-Funded Debt Buybacks to Quietly Rewrite Its Capital Playbook?

Pitney Bowes Inc. recently launched cash-funded tender offers to buy back up to US$50,000,000 of its 6.70% Notes due 2043 and 5.250% Medium-Term Notes due 2037, with the offers scheduled to expire on September 18, 2026. This move to retire a portion of its long-dated debt using cash on hand could reshape Pitney Bowes’ balance sheet and interest expense profile. Now we’ll examine how this cash-funded reduction of long-dated debt affects Pitney Bowes’ investment narrative and future capital...
NYSE:IONQ
NYSE:IONQSemiconductor

Where Does IonQ (IONQ) Value Sit After Its Space Network Progress?

IonQ stock has delivered a very large 5 year gain, yet on broad valuation checks it currently screens as expensive rather than a clear bargain. With fresh news around space focused optical terminals, new quantum chemistry tools and manufacturing expansion, investors are weighing how much of IonQ’s story is already reflected in the share price. Over 5 years, IonQ has returned about 301.5% which puts recent share price weakness into context and raises the question of how much long term upside...
NYSE:UNH
NYSE:UNHHealthcare

Abbott Stock And Two Defensive Dividend Names For Uncertain Markets

Sticky July PCE inflation and a divided Federal Reserve keep markets on edge, while softer retail sales hint that consumers may be slowing down. That mix can punish some stocks and reward others, especially companies with steadier cash flows and dividends. This article looks at three high quality dividend stocks that appear closely linked to these cross currents and explains how the latest data could shape their risk and reward profile for your portfolio. The three dividend stocks below are...
NYSE:FN
NYSE:FNElectronic

Fabrinet (FN) Posted Record Q4 Results, Is The Stock Cheap Or Pricey?

Fabrinet (FN) stock is in focus after the company reported record fourth quarter results, with revenue of $1.316b and higher earnings per share, alongside fresh guidance and a revised revenue reporting structure. Despite Fabrinet's strong Q4 2026 report and new revenue guidance, the stock has pulled back recently, with a 30 day share price return of down 7% and a 90 day share price return of down 34.5% from recent highs. At the same time, the 1 year total shareholder return is 31.7% and the 5...